Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-13

Clinical Trial Update: Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis [NA]

View source ↗

Summary

This clinical trial update describes a program in the Central Denmark Region that offers biannual ultrasound and alpha-fetoprotein screening to detect hepatocel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Aarhus | Conditions: Hepatocellular Carcinoma (HCC), Cirrhosis | NA | Status: RECRUITING